predominantly soft tissue from the hallux with a small sliver of subungual bone to aid stability, and using an iliac crest bone graft to reconstruct a missing phalanx. Upton5 further modified whole thumb reconstruction by using part of the distal phalanx of the hallux and reducing the width of the toe nail by one-third. In 1990 Morrison6 refined the technique he had first described 10 years previously, by using the wrap-around, taking no bone and reducing the width of the thumbnail by excising both lateral margins of the germinal matrix from within to leave the paronychial folds intact.
Our patient required a nail, nailbed, sensate pulp and soft tissue to cover the intact but exposed tendinous and bony elements, and thus a wrap-around was the ideal choice. No preoperative angiogram was performed, the patient being judged clinically to have adequate pulses. Support for this course of action is provided by the work of Isenberg7, who has shown that a thorough preoperative and intraoperative clinical evaluation of the relevant arteries can abolish the requirement for a preoperative angiogram.
In reconstruction of thumb soft tissue loss, the wraparound offers a means to restore function as well as appearance and we recommend harvesting of the plantar artery, in addition to the metatarsal, whenever possible. Modern treatment of acute leukaemia can lead to long-term survival and cure, but part of the price paid is late development of complications due to chemotherapy and radiotherapy. One of these is hypopituitarism.
Littley and co-workers1'2 state that, in children who have received prophylactic cranial irradiation for acute lymphoblastic leukaemia, the main effect is on growth hormone secretion. In adults the effects of external radiotherapy on pituitary function have been less clearly documented. Here we report the case of a middle-aged man in whom hypopituitarism developed after successful treatment of acute lymphoblastic leukaemia.
CASE HISTORY
A man aged 53 was admitted in January 1986 with a 5week history of left-sided chest and abdominal pain, difficulty in breathing and weight loss. Acute lymphoblastic leukaemia was diagnosed, and blast cells were present in the cerebrospinal fluid. He was entered in the Medical Research Council trial MRC UK ALL XA and initially received intravenous vincristine and daunorubicin, intramuscular asparaginase, oral prednisolone and intrathecal methotrexate 12.5mg weekly for 6 weeks. Bone marrow a month later was cellular and the leukaemia was in remission. In March 1986 he received craniospinal radiotherapy-24 Gy MPD in 10 fractions daily on an 8 MEV linear accelerator. Complications of treatment included steroid-related diabetes mellitus and a pseudomonas ear infection. Chemotherapy was finished in February 1988, when bone marrow examination indicated that he was still in remission.
In September 1986 he fell and fractured the neck of his left femur. Internal fixation was required and the postoperative course was complicated by pulmonary embolism for which he was anticoagulated. According to the MRC trial protocol, he had been receiving prednisolone 90mg daily for 5 days every four weeks. Histology of the bone fragment from fracture site showed thin trabeculae and poor cellularity of the marrow.
In January 1992 he reported depressed libido and initial investigations showed low levels of serum testosterone. An endocrinologist then noticed that he appeared myxoedematous, overweight and pale with loss of axillary and body hair. The testes were small (8mL bilaterally) and soft. Serum testosterone was low at 3.3 nmol/L (normal 11-36); follicle stimulating hormone, luteinizing hormone, and prolactin were all within normal limits (1.1 IU/L, 2.0 IU/L, 170 mU/L) but free thyroxine was low at 9.3 pmol/L in the setting of a normal thyroid stimulating hormone at 1.6mU/L (0.5-4.5). A corticotropin test showed peak cortisol level of 390 nmol/L. In view of this low response an insulin tolerance test was done: in the face of adequate and symptomatic hypoglycaemia peak plasma cortisol was 490nmol/L and maximum serum growth hormone was 1.3mU/L. Computed tomographic scan of the pituitary gland was normal. From these tests it was concluded that he had anterior pituitary failure. He was treated with hydrocortisone 20 mg in the morning and 10mg in the evening, L-thyroxine 100 jig daily, and intramuscular Sustanon (a testosterone preparation) 250mg every three weeks. During follow-up he improved from the endocrine aspect and the leukaemia remained in remission. COMMENT The first possible complication of his treatment was the fracture to his femur. Perhaps it was due to steroidinduced osteoporosis but this becomes less likely when we see that he continued steroids for two years without further bone troubles. What of the pituitary failure (hypogonadism, hypoadrenalism, growth hormone deficiency, hypothyroidism) that developed six years later?
This might have been a late manifestation of damage due to the leukaemia itself3; or it might have been fortuitous, unrelated to the leukaemic episode. We suspect, however, that it was connected with the treatment of the leukaemia. The treatment most often implicated in pituitary failure is radiotherapy to the brain; however, this is usually given with intrathecal methotrexate so analysis of their separate contributions is difficult4. In adults treated for brain or pituitary tumours, radiotherapy related hypopituitarism is well documented5 but this is not true of adults wvith acute lymphoblastic leukaemia. Since the onset is usually insidious and the treatment is very rewarding, we would encourage suitable investigations in long-term survivors of acute leukaemia who have suspicious symptoms. If similar cases are reported in the future further research may be needed. dysfunction after radiation for brain tumours. N Engi J Med Depot antipsychotics are used in the maintenance treatment of schizophrenia, bipolar affective disorder and organic psychoses. They can also be used to manage non-psychotic behavioural disturbance in selected patients with learning disability, dementia and personality disorder. Administration by community psychiatric nurses or in special 'depot clinics' has long been practised and depot antipsychotics are increasingly given by general practitioners and practice nurses in liaison with community psychiatric teams. Depot antipsychotics are long-acting drug preparations whose adverse effects can be difficult to reverse. They should be initiated only after careful assesssment and should form part of individually tailored treatment plans where the patient's physical and mental state will be monitored closely.
CASE HISTORIES

Case I
A 44-year-old male remand prisoner told medical staff he had been diagnosed as having schizophrenia and had St Cadoc's Hospital, Caerleon, Gwent NP6 1XQ, UK
